Cargando…
MON-LB052 Efficacy and Safety of Minimed 670G Automode in Children with Type 1 Diabetes Less Than 8 Years Old
Introduction: The Medtronic MiniMed 670G system with SmartGuardTM (Medtronic, Northridge, CA) is a commercial hybrid closed-loop (HCL) system approved for use in 2017 for children >8 years of age. Studies of the system in children >7 years old, adolescents, and adults show improvement in glyce...
Autores principales: | Salehi, Parisa, Roberts, Alissa, Kim, Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551136/ http://dx.doi.org/10.1210/js.2019-MON-LB052 |
Ejemplares similares
-
SAT-LB052 Intravenous Bisphosphonate Therapy in Children with Spinal Muscular Atrophy
por: Nasomyont, Nat, et al.
Publicado: (2019) -
SUN-LB052 Sexual Precocity in a Male Toddler Caused by Inadvertent Prolonged Exposure to Exogenous Testosterone
por: Azova, Svetlana, et al.
Publicado: (2019) -
Medtronic MiniMed 670G Auto Mode: Implications for Clinical Practice
por: Dos Santos-Marinho, Jeanne, et al.
Publicado: (2021) -
MON-LB015 Sporadic MTC in Children: Characterization of a Rare Disease
por: Gammons, Sarah, et al.
Publicado: (2020) -
MON-LB011 Retrospective Comparison of Cystic Fibrosis Related Diabetes Pediatric Screening Rates
por: Alkhatib, Einas H, et al.
Publicado: (2020)